02:23 PM EDT, 06/25/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Wednesday that the US Food and Drug Administration has cleared its investigational new drug application for Reyobiq, paving the way for a phase 1/2a trial targeting pediatric patients with recurrent or progressive high-grade glioma and ependymoma.

Shares surged 69% with intraday trading volume jumping to more than 669.1 million from a daily average of about 9.21 million.

GlucoTrack ( GCTK ) said Wednesday the first human trial of its continuous blood glucose monitor met all primary and secondary endpoints.

Shares jumped 32% as intraday trading volume soared to over 22.8 million compared with a daily average volume of about 82,000.

SeaStar Medical ( ICU ) said Wednesday it is awaiting formal confirmation from Nasdaq that it has regained compliance with the exchange's $2.5 million stockholders' equity requirement.

The company said its recent capital transactions and operational improvements suggest compliance has been achieved.

Shares jumped 19% as intraday trading volume catapulted to over 265.1 million, versus a daily average volume of about 636,000.

Price: 0.32, Change: +0.13, Percent Change: +68.98